Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/12/2018
SIETES contiene 92610 citas

 
 
 1 a 15 de 15 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Kamali KN, Lloyd-Jones DM, van der Leeuw J, Goff Jr DC, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J, on behalf of the Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data. PLOS Medicine 2018:20 de marzo. [Ref.ID 102591]
3.Tiene citas relacionadas Cita con resumen
Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JFF, Wilson M, Mehta Z, Meade TW. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012;379:1602-12. [Ref.ID 92737]
4.Tiene citas relacionadas Cita con resumen
Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JFF, Wilson M, Mehta Z, Meade TW. Short term effects of daily aspirin on cancer incidence, mortality, and non-vascular deaths: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012;379:1602-12. [Ref.ID 92438]
5. Cita con resumen
Mancia G, Parati G, Revera M, Bilo G, Giuliano A, Veglia F, Crepaldi G, Zanchetti A. Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial. BMJ 2010;340:846. [Ref.ID 88340]
6.Tiene citas relacionadas Cita con resumen
Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, Hua T, Laragh JH, McInnes GT, Mitchell L, Plat F, Schork MA, Smith B, Zanchetti A. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004;363:2049-51. [Ref.ID 70484]
7.Tiene citas relacionadas Cita con resumen
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, for the VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-31. [Ref.ID 70481]
8.Tiene citas relacionadas Cita con resumen
Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton J D, Grimm RH, Hansson L, Lacourcière Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Andeers RJ, for the CONVINCE Research Group. Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial. JAMA 2003;289:2073-82. [Ref.ID 65827]
9.Tiene citas relacionadas
Zanchetti A. Perindopril 2mg/indapamide 0.625mg: viewpoint. Drugs 1999;58:303-4. [Ref.ID 46288]
10.Tiene citas relacionadas Cita con resumen
Zanchetti A, Hansson L, on behalf of the HOT Executive Committee. Risk of major gastrointestinal bleeding with aspirin. Author's reply (HOT Study). Lancet 1999;353:149-50. [Ref.ID 42483]
11.Tiene citas relacionadas
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn K H, Wedel H, Westerling S, for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62. [Ref.ID 38877]
12.Tiene citas relacionadas Cita con resumen
Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, De Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio Jl, Tuomilehto J, Zanchetti A, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64. [Ref.ID 35354]
13.
Zanchetti A. Clinical profile of lercanidipine. J Cardiovasc Pharmacol 1997;29:S1-S58. [Ref.ID 33898]
14.
Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet 1997;349:454-7. [Ref.ID 31253]
15.
Elmfeldt D, Lorimer AR, Zanchetti A, Guest editors. Second Intercontinental Meeting on Felodipine. Drugs 1987;34:1-209. [Ref.ID 11419]
Seleccionar todas
 
 1 a 15 de 15